Mesoblast Limited (ASX:MSB) Financial Year End Results: Strong Clinical Progress, Major Regulatory Milestone and Enhance

  Melbourne, Australia, Aug 26, 2010 - (ABN Newswire) - Australia's regenerative medicine company, Mesoblast Limited (ASX:MSB) (PINK:MBLTY), today reported its results for the year ended 30 June 2010.With cash reserves of A & #36;32.05 million at 30 June 2010 compared to A & #36;16.  

Sydney

  [ Change ]
 
Today

Min: 12°
Max: 19°
Possible afternoon shower.
Tomorrow

Min: 12°
Max: 19°
Possible afternoon shower.
 

Account

Login

To access your account and listings



Remember me
   
   
   
 
 
Find Hunter Valley accommodation online